SCHEMBL4783992

SCHEMBL4783992

CCSc1cc(Cl)ccc1-c1ncc[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 2/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP19A1 P11511 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
NISCH Q9Y2I1 2/20 0.37
MAPT P10636 1/20 0.36
GSK3B P49841 1/20 0.36
MC4R P32245 1/20 0.35
MTOR P42345 1/20 0.35
ADK P55263 1/20 0.35
TAAR1 Q96RJ0 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8539543 0.84 SMN1; SMN2 (0.41) NPC1RAB9AALDH1A1MAPK1HPGD
SCHEMBL8536874 0.81 CSNK1A1 (0.45) NPC1ALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL8538107 0.78 MAPT (0.43) NPC1RAB9AALDH1A1SMN1; SMN2CYP3A4
SCHEMBL3631532 0.75 RAB9A (0.50) NPC1RAB9AALDH1A1SMN1; SMN2NISCH
SCHEMBL8541400 0.75 MC4R (0.37) NPC1RAB9AALDH1A1MAPK1HPGD
SCHEMBL8539541 0.74 CYP1A2 (0.43) NPC1RAB9AALDH1A1MAPK1SMN1; SMN2
SCHEMBL8542466 0.74 ALDH1A1 (0.49) NPC1RAB9AALDH1A1MAPK1CYP1A2
SCHEMBL31429694 0.74 IDO1 (0.51) NPC1RAB9AALDH1A1CYP3A4CYP19A1
SCHEMBL8537063 0.72 NR4A2 (0.43) NPC1RAB9AALDH1A1MAPK1HPGD
SCHEMBL29084865 0.72 IDO1 (0.58) NPC1RAB9AALDH1A1MAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008029152-A2 TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY SUMMIT CORPORATION PLC (GB) 2008-03-13 WO disclosed
EP-0857171-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1998-08-12 EP disclosed
WO-1997015555-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1997-05-01 WO disclosed